Around the world healthcare agencies and payers are demanding economic analyses to help them to understand the cost/benefit and budgetary impact of new drugs and medical devices. Safety and efficacy studies are not longer sufficient for optimal market access. Bridgehead provides its clients with the information and insight necessary to address these issues, including:
For further information please contact us now.
